Biogen on aducanumab: ‘We’re ready for an immediate launch’
Biogen expects to begin shipping Aduhelm (aducanumab-avwa) in two weeks: after the FDA granted the Alzheimer's drug accelerated approval on Monday.
Archives for June 9, 2021
NPD Gallery: Technology Insider
What's new in the world of biopharmaceutical tech this month? We track developments in process innovation equipment.
What’s in a name? Quite a lot actually when it comes to substances used in cell and gene therapies
The World Health Organization (WHO), as part of its International Nonproprietary Names (INN) system, has recently made progress in developing and harmonizing the definition paragraphs that support the naming of cell-based substances.